Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Liuying Township, Taiwan Clinical Trials

A listing of Liuying Township, Taiwan clinical trials actively recruiting patients volunteers.

Found (48673) clinical trials

All trial-related visits, tests, and medications will be provided to participants at no cost. In addition, compensation for time and/or travel may be provided.

Phase

All trial-related visits, tests, and medications will be provided to participants at no cost. In addition, compensation for time and/or travel may be provided.  

Phase

Participants will complete: 1 screening visit 4 consecutive overnights 3 outpatient visits To determine if you fully qualify, it will be necessary to obtain blood samples after an 8-hour fast. You have the option of fasting for the screening appointment, or, you may return at a later date. If ICON does …

Phase N/A

Participants will complete: 1 screening visit 1 day in-clinic 11 outpatient visits To determine if you fully qualify, it will be necessary to obtain blood samples after an 8- hour fast.  You have the option of fasting for the screening appointment, or, you may return at a later date. If ICON …

Phase N/A

Compensation for time and travel Study medication at no cost

Phase N/A

The Memory Health Center at Summit Research Network, is enrolling participants in the Clarity AD Research Study.  This research study will evaluate whether an investigational study drug is safe and effective in slowing the progression of Alzheimer’s. Study participation may last to up 23 months with the option to participate …

Phase N/A

The Memory Health Center at Summit Research Network, is enrolling participants in a new mild Alzheimer’s clinical trial. This trial will evaluate the safety and effectiveness of the study medication, azeligaron in the treatment of mild Alzheimer’s disease in patients who also have glucose intolerance or Type 2 Diabetes: those …

Phase

Study participation will last about a year.   Following a screening period of up to 6 weeks, qualified participants will be randomly assigned to the oral investigational medication, C0R388, or a placebo (an inactive substance).   During the treatment period, the participants will visit the research center 9 times over a 48 …

Phase